Voyageur Pharmaceuticals proposes converting $192,300 debt into shares at $0.155 each
Bitget2026/09/24 21:53- Voyageur Pharmaceuticals proposed converting $192,300 of debt into common shares to conserve cash.
- Settlement priced at $0.155 per share, implying issuance of 1,240,644 common shares.
- $52,300 owed to an officer to be settled with 337,419 shares.
- $140,000 owed to other creditors to be settled with 903,225 shares.
- Closing subject to regulatory sign-off, including TSX Venture Exchange final acceptance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
